등록자료 카탈로그 · 폐암 (NSCLC)

172개 · 저장 분류: ADC 22 · 항체 등 120 · CGT 30 · 선정 등록 36건 대조 2026-11-02

자동 수집 등록자료가 포함된 탐색용 목록입니다. 약물별 상세 해설 검토가 끝난 목록과 구분하며 이 목록 화면은 검색 색인 대상에서 제외합니다. 등록 단계·시험 수는 효능 또는 경쟁력의 판정이 아닙니다.

인기최근 업데이트큐레이션임상 많은갱신 필요최신Phase 3FDA승인프로그램 172개
CGTLimited Data등록자료 · 상세 해설 미완료Chongqing Precision Biotech Co.…Phase 1

Targeted CEA CAR-T (Targeted CEA CAR-T)

Advanced Lung Cancer · CEA

#CEA#세포·유전자 치료#Phase1#세포유전치료#CAR-T+2
저장된 시험 연결 19상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Merck Sharp & Dohme LLCPhase 2

Vibostolimab (Vibostolimab)

Neoplasm Metastasis · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#항체#Phase2#면역항체#NeoplasmMetastasis+1
저장된 시험 연결 19상태 RECRUITING
ADCCurated Core등록자료 · 상세 해설 미완료Merck Sharp & Dohme LLCPhase 3

Ifinatamab deruxtecan (Ifinatamab deruxtecan)

Recurrent or Metastatic Solid Tumors · Small Cell Lung Cancer

#SmallCellLungCancer#ADC#Phase3#바이오정보모아추천#항체약물접합체+2
저장된 시험 연결 18상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료StemcentrxPhase 1

Rovalpituzumab Tesirine (Rovalpituzumab Tesirine)

Small Cell Lung Carcinoma · Small Cell Lung Cancer

#SmallCellLungCancer#항체#Phase1#면역항체#SmallCellLungCarcinoma+1
저장된 시험 연결 13상태 ACTIVE
ADCLimited Data등록자료 · 상세 해설 미완료AbbViePhase 2

Telisotuzumab Adizutecan (Telisotuzumab Adizutecan)

Metastatic Colorectal Cancer · Non Small Cell Lung Carcinoma

#NonSmallCellLungCarcinoma#ADC#Phase2#항체약물접합체#MetastaticColorectalCancer+1
저장된 시험 연결 13상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료AstraZenecaPhase 1

durvalumab (Imfinzi, Administration of ceralasertib and durvalumab)

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer · Adv Solid Malig - H&N SCC, ATM Pro / Def

#AdvSolidMalig-HNSCCATMProDef#항체#Phase1#면역항체#AdvSolidMalig-HNSCC+3
저장된 시험 연결 12상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료RochePhase 3

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma

#LungNon-SmallCellCarcinoma#항체#Phase3#면역항체#StageIILungCancerAJCCv8+1
저장된 시험 연결 7상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료Merck Sharp & Dohme LLCPhase 2

Raludotatug deruxtecan (Raludotatug deruxtecan)

Carcinoma, Non-Small-Cell Lung · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#Carcinoma+2
저장된 시험 연결 7상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Merck Sharp & Dohme LLCPhase 2

Boserolimab (Boserolimab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#항체#Phase2#면역항체#Carcinoma+2
저장된 시험 연결 5상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료Seagen Inc.Phase 2

ladiratuzumab vedotin (ladiratuzumab vedotin)

Small Cell Lung Cancer; Non-small Cell Lung Cancer, Squamous · HER2

#HER2#ADC#Phase2#항체약물접합체#SmallCellLungCancer+3
저장된 시험 연결 5상태 ACTIVE
ADCLimited Data등록자료 · 상세 해설 미완료Seagen, a wholly owned subsidia…Phase 1

sigvotatug vedotin (sigvotatug vedotin)

Carcinoma, Non-Small Cell Lung; Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small Cell Lung

#CarcinomaNon-SmallCellLung#ADC#Phase1#항체약물접합체#Carcinoma+3
저장된 시험 연결 5상태 RECRUITING
ADCLimited Data등록자료 · 상세 해설 미완료Merck Sharp & Dohme LLCPhase 2

5-hydroxytryptamine subtype 3 receptor antagonist (5-hydroxytryptamine subtype 3 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#Carcinoma+2
저장된 시험 연결 4상태 RECRUITING
CGTLimited Data등록자료 · 상세 해설 미완료The Catholic University of KoreaPhase 2

Ex vivo-expanded NK cell enriched lymphocytes (ANKL, ANKL(Ex vivo-expanded NK cell enriched lymphocytes))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#세포·유전자 치료#Phase2#세포유전치료#CAR-T+1
저장된 시험 연결 4상태 ACTIVE
CGTLimited Data등록자료 · 상세 해설 미완료Beijing BiotechPhase 2

DLL3-CAR-NK cells (DLL3-CAR-NK cells)

Extensive Stage Lung Small Cell Cancer · SCLC, Extensive Stage

#SCLCExtensiveStage#세포·유전자 치료#Phase2#세포유전치료#CAR-T+2
저장된 시험 연결 4상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료BeiGenePhase 1

atezolizumab (Tecentriq, Tislelizumab，atezolizumab or sugemalimab)

NSCLC · NSCLC

#NSCLC#항체#Phase1#면역항체#BeiGene
저장된 시험 연결 4상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Peregrine PharmaceuticalsPhase 2

bavituximab (bavituximab)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#항체#Phase2#면역항체#Peregrine
저장된 시험 연결 4상태 ACTIVE
AntibodyLimited Data등록자료 · 상세 해설 미완료Bristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab)

Liver Cancer; Antibody · Lung Cancer

#LungCancer#항체#Phase2#면역항체#LiverCancer+2
저장된 시험 연결 4상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료Bristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab)

Hepatic Cancer; Surgery · Lung Cancer

#LungCancer#항체#Phase2#면역항체#HepaticCancer+2
저장된 시험 연결 4상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료The First Affiliated Hospital o…Phase 2

Adebellizumab (Adebellizumab)

Resectable Lung Non-Small Cell Carcinoma · Resectable Lung Non-Small Cell Carcinoma

#ResectableLungNon-SmallCellCarci#항체#Phase2#면역항체#The
저장된 시험 연결 3상태 RECRUITING
AntibodyLimited Data등록자료 · 상세 해설 미완료GenmabPhase 2

Acasunlimab (Acasunlimab)

Non Small Cell Lung Cancer Metastatic · Non Small Cell Lung Cancer Metastatic

#NonSmallCellLungCancerMetastatic#항체#Phase2#면역항체#Genmab
저장된 시험 연결 2상태 RECRUITING

3 / 9 pages

← PreviousNext →